Prevalence of HIV among drug users by world region 2017

Prevalence of HIV among drug users in 2017, by world region*

by John Elflein, last edited Jul 3, 2019
Prevalence of HIV among drug users by world region 2017 This statistic shows the prevalence of HIV among injection drug users in 2017, sorted by WHO world sub-regions. In that year, some 6.9 percent of users of injection drugs in North America were HIV-positive.
Show more

Prevalence of HIV among drug users in 2017, by world region*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Global drug use
Global drug use

All Information
in one Presentation

Global drug use

Everything On "Global drug use" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Global HIV/AIDS epidemic"
  • Overview
  • Prevalence
The most important statistics
  • Other HIV figures
  • AIDS deaths
  • Spending/funding
  • Treatment
  • HIV and tuberculosis
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.